Disease/Infection News

RSS

Two new oral medications post-transplant is safe, beneficial for patients with hepatitis C

All patients with hepatitis C who receive a liver transplant will eventually infect their new livers. These transplanted organs then require anti-viral treatment before they become severely damaged. But traditional post-transplant hepatitis C therapy can take up to a year, is potentially toxic and can lead to organ rejection.

11 Nov 2014

New study finds that it is possible to distinguish between different hemorrhagic fevers

A new study has found it is possible to distinguish between different hemorrhagic fevers, including Marburg (Ebola cousin) and Lassa before the person becomes symptomatic.

11 Nov 2014

Survey: Majority of U.S. adult women do not believe that they are up to date on vaccinations

A national survey from Rite Aid and National Foundation for Infectious Diseases reveals that the majority of adult women living in the United States do not believe they are up to date on vaccinations to protect against many preventable diseases.

11 Nov 2014

New model explains how immune cells recognize, destroy bacteria

The innate immune system serves as the body's specialized armed forces division, comprised of a host of defense mechanisms used to battle bacterial infections. Among the system's warriors are white blood cells including the specialized macrophages, which maintain constant surveillance for foreign intruders or pathogens, functioning as the body's first line of defense, poised to attack at barrier sites including the skin, lungs and intestines.

11 Nov 2014

U of T, Chematria and IBM partner to find new treatments for Ebola virus

The University of Toronto, Chematria and IBM are combining forces in a quest to find new treatments for the Ebola virus.

11 Nov 2014

Resonance Health launches new diagnostic imaging solution for patients with fatty liver disease

ASX listed Resonance Health officially launched an innovative new diagnostic imaging solution for liver patients worldwide at the American Association for the Study of Liver Diseases annual conference in Boston this week.

10 Nov 2014

BioInfect 2014 conference explores global anti-microbial agenda

This year’s unique BioInfect conference organised by Bionow, a not for profit membership organisation for the biomedical / life-sciences industry,was a major success.

10 Nov 2014

LSTM receives research grants to develop Experimental Human Pneumococcal Carriage model

Respiratory specialists at Liverpool School Tropical Medicine (LSTM) have been awarded two substantial research grants to further develop and utilise their Experimental Human Pneumococcal Carriage (EHPC) model.

10 Nov 2014

UF Health researcher finds way to grow human norovirus

Noroviruses are pernicious intestinal viruses. They cause violent vomiting and diarrhea, and people ill with the virus remain contagious up to three days after they seem to recover.

9 Nov 2014

LSTM awarded research grants to develop Experimental Human Pneumococcal Carriage model

Respiratory specialists at Liverpool School Tropical Medicine have been awarded two substantial research grants to further develop and utilise their Experimental Human Pneumococcal Carriage (EHPC) model.

7 Nov 2014

Liposomes can help prevent bacterial toxins from killing human cells

Published in Nature Biotechnology, the study at the University of Liverpool showed that specially engineered lipid (fat) bodies, called liposomes, can be used to prevent bacterial toxins from killing human cells.

7 Nov 2014

Researchers synthetize molecules to block virus that causes influenza A

The influenza A virus is a contagious and severe respiratory infection that affects animals but also humans. Researchers from the University of Barcelona have synthetized some molecules which are able to block the virus that causes influenza A and some of the mutations that make it resistant to common drugs.

7 Nov 2014

Greenwich Hospital partners with ONSF to conduct research on surgical site infections

Research on surgical site infections conducted at Greenwich Hospital in alliance with the ONS Foundation for Clinical Research and Education examined why a certain bacteria is so common in post-surgical shoulder infections and are helping to develop tactics to control it.

7 Nov 2014

Obeticholic acid improves liver health in people with nonalcoholic steatohepatitis

An experimental drug aimed at treating a common liver disease showed promising results and potential problems in a multicenter clinical trial funded by the National Institutes of Health. The FLINT study found that people with nonalcoholic steatohepatitis (NASH) who took obeticholic acid (OCA) had improved liver health during that period, including decreased inflammation and fat in the liver and decreased body weight versus people receiving a placebo. OCA was also associated with increases in itching and total cholesterol.

7 Nov 2014

Chikungunya outbreak in Caribbean, Central and South America continues to spread

Fall in the United States means residents in most of the country will see fewer mosquitoes and less risk of the diseases they spread. However, the chikungunya outbreak in Caribbean and Central and South American countries continues to spread with no sign of slowing down. Experts at the Centers for Disease Control and Prevention are warning that the painful mosquito-borne disease will likely continue to infect travelers to the region during the rest of this year and beyond.

7 Nov 2014

BIOVISION's 10th edition to focus on today’s health challenges

BIOVISION, the annual life sciences forum organized by the Foundation for the University of Lyon, today announces its 10thedition, which will take place on April 15 and 16, 2015 at the Musée des Confluences in Lyon, France.

6 Nov 2014

Janssen working with The Union to evaluate SIRTURO (bedaquiline) in patients with MDR-TB

Janssen Research & Development, LLC today announced a collaboration with the International Union Against Tuberculosis and Lung Disease (The Union) to include SIRTURO (bedaquiline) in the STREAM Study.

6 Nov 2014

Study highlights connections between climate change and new outbreak of diseases

Climate change may affect human health directly or indirectly. In addition to increased threats of storms, flooding, droughts, and heat waves, other health risks are being identified. In particular, new diseases are appearing, caused by infectious agents (viruses, bacteria, parasites) heretofore unknown or that are changing, especially under the effect of changes in the climate (change of host, vector, pathogenicity, or strain).

6 Nov 2014

Joseph Assignment Global Initiative to send lifesaving medical items to Liberia and Sierra Leone

The Joseph Assignment Global Initiative, in cooperation with New Faith Baptist Church International will send lifesaving medical items to its teams in Liberia and Sierra Leone to assist doctors on the front line fighting to contain Ebola in West Africa.

6 Nov 2014

Non-injectable vaccine may provide long-term protection against deadly Ebola virus

A potentially breathable, respiratory vaccine in development has been shown to provide long-term protection for non-human primates against the deadly Ebola virus, as reported this week in the online edition of the journal Molecular Pharmaceutics.

5 Nov 2014

Disease/Infection News

Two new oral medications post-transplant is safe, beneficial for patients with hepatitis C

New study finds that it is possible to distinguish between different hemorrhagic fevers

Survey: Majority of U.S. adult women do not believe that they are up to date on vaccinations

New model explains how immune cells recognize, destroy bacteria

U of T, Chematria and IBM partner to find new treatments for Ebola virus

Resonance Health launches new diagnostic imaging solution for patients with fatty liver disease

BioInfect 2014 conference explores global anti-microbial agenda

LSTM receives research grants to develop Experimental Human Pneumococcal Carriage model

UF Health researcher finds way to grow human norovirus

LSTM awarded research grants to develop Experimental Human Pneumococcal Carriage model

Liposomes can help prevent bacterial toxins from killing human cells

Researchers synthetize molecules to block virus that causes influenza A

Greenwich Hospital partners with ONSF to conduct research on surgical site infections

Obeticholic acid improves liver health in people with nonalcoholic steatohepatitis

Chikungunya outbreak in Caribbean, Central and South America continues to spread

BIOVISION's 10th edition to focus on today’s health challenges

Janssen working with The Union to evaluate SIRTURO (bedaquiline) in patients with MDR-TB

Study highlights connections between climate change and new outbreak of diseases

Joseph Assignment Global Initiative to send lifesaving medical items to Liberia and Sierra Leone

Non-injectable vaccine may provide long-term protection against deadly Ebola virus

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News